Genmab A/S buy tbackenh
Start price
14.03.14
/
50%
€31.91
Target price
18.03.14
€37.50
Performance (%)
0.00%
End price
18.03.14
€31.91
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genmab A/S | -0.694% | -0.694% | -29.557% | -38.827% |
| iShares Core DAX® | 1.665% | 1.692% | 18.093% | 15.353% |
| iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% | 36.314% |
| iShares Nikkei 225® | 2.620% | 4.475% | 17.651% | 10.750% |
| iShares S&P 500 | -0.091% | 1.099% | 24.873% | 36.740% |
Comments by tbackenh for this prediction
In the thread Genmab A/S diskutieren
Genmab AS
Biotechnologie aus dem Nachbarland Dänemark! Trotz der relativ kleinen Marktkapitalisierung ein interessanter Wert mit guten Wachstumsaussichten.